miR-29b expression is associated with disease-free survival in patients with ovarian serous carcinoma.
Flavin R, Smyth P, Barrett C, Russell S, Wen H, Wei J, Laios A, O'Toole S, Ring M, Denning K, Li J, Aherne S, Sammarae D, Aziz NA, Alhadi A, Finn SP, Loda M, B S, Sheils O, O'Leary JJ.
Flavin R, et al.
Int J Gynecol Cancer. 2009 May;19(4):641-7. doi: 10.1111/IGC.0b013e3181a48cf9.
Int J Gynecol Cancer. 2009.
PMID: 19509563